首页> 美国卫生研究院文献>Acta Naturae >The Mechanism of Fluorescence Quenching of Protein Photosensitizers Based on miniSOG During Internalization of the HER2 Receptor
【2h】

The Mechanism of Fluorescence Quenching of Protein Photosensitizers Based on miniSOG During Internalization of the HER2 Receptor

机译:基于miniSOG的HER2受体内部化过程中蛋白质光敏剂的荧光猝灭机理。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。
获取外文期刊封面目录资料

摘要

The protein photosensitizer miniSOG is a promising agent for photodynamic therapy. The genetically encoded phototoxins 4D5scFv-miniSOG and DARPin-miniSOG specifically bind to the HER2 receptor overexpressed on the surface of cancer cells and promote receptor-mediated internalization of HER2. We show that ingestion of proteins in a complex with the receptor reduces the fluorescent signal of the phototoxic module in endosomes. In order to clarify the mechanism of decrease in the fluorescence intensity of miniSOG-based proteins as they enter a cancer cell during internalization, we analyzed the influence of different factors, including low pH, proteolysis, cofactor reduction, and shielding, on changes in the fluorescence of photosensitizers. Shielding and absorption of miniSOG fluorescence by cell fluorophores, including cytochrome c, were found to contribute significantly to the changes in the fluorescent properties of miniSOG.
机译:蛋白质光敏剂miniSOG是用于光动力疗法的有前途的药物。遗传编码的光毒素4D5scFv-miniSOG和DARPin-miniSOG与癌细胞表面过表达的HER2受体特异性结合,并促进HER2受体介导的内在化。我们显示蛋白质与受体的复合物的摄入减少了内体中光毒性模块的荧光信号。为了阐明基于miniSOG的蛋白质在内化过程中进入癌细胞时荧光强度降低的机理,我们分析了低pH,蛋白水解,辅因子减少和屏蔽等不同因素对蛋白质变化的影响。光敏剂的荧光。发现miniSOG荧光被细胞荧光团(包括细胞色素c)的屏蔽和吸收显着影响miniSOG荧光特性的变化。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号